Cellulitis - Selulitishttps://en.wikipedia.org/wiki/Cellulitis
Selulitis (Cellulitis) nyaéta inféksi baktéri anu ngalibatkeun lapisan jero kulit. Salaku tanda jeung gejala, wewengkon nyeri tina redness naek dina ukuran salila sababaraha poé. Batesan daérah anu kemerahan umumna henteu dibédakeun sareng kulitna tiasa ngabareuhan. Wewengkon inféksi biasana nyeri. Hiji jalma tiasa muriang sareng myagia.

Suku sareng raray mangrupikeun situs anu paling umum. Faktor résiko kalebet obesitas, bareuh suku, sareng umur sepuh. Baktéri anu paling sering kalibet nyaéta streptococci sareng Staphylococcus aureus.

Pangobatan biasana nganggo antibiotik anu dicandak ku sungut, sapertos cephalexin, amoxicillin atanapi cloxacillin. Sakitar 95% jalma langkung saé saatos 7 dugi ka 10 dinten perlakuan. Jalma anu nganggo diabetes, kumaha oge, sering gaduh hasil anu langkung parah.

Selulitis mangrupikeun gangguan umum, sareng di Inggris, selulitis mangrupikeun alesan pikeun 1,6% pangakuan ka rumah sakit. Cellulitis dina 2015 nyababkeun sakitar 16,900 maotna di dunya.

Perlakuan - Narkoba OTC
Selulitis canggih merlukeun perlakuan ku antibiotik prescribed ngan ku dokter. Lamun lesion progresses gancang sarta dibarengan ku muriang jeung chills, éta sasaena ningali dokter pas mungkin.
Nerapkeun hiji salep antibiotik over-the-counter ka lesions mimiti bisa mantuan. Upami salep diterapkeun teuing ipis, éta moal tiasa dianggo.
#Polysporin
#Bacitracin
#Betadine

Anggo panawar nyeri OTC sapertos acetaminophen pikeun ngagentos nyeri.
#Ibuprofen
#Naproxen
#Acetaminophen

Jaga suku tetep bersih sareng ngubaran suku atlit sabab suku atlit ningkatkeun résiko selulitis.

Perlakuan
#First-generation cephalosporins (e.g. Cefradine)
#Bacterial culture
#Third-generation cephalosporins (e.g. Cefditoren Pivoxil)
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
  • Leg nyaeta lokasi umum pikeun Selulitis (Cellulitis).
  • Kasus biasa
  • Selulitis (Cellulitis) ― tahap penyembuhan
  • Cellulitis dina leg kénca. Upami éta nyebar sacara lega, muriang luhur tiasa kajantenan, nyababkeun shock septic anu ngancam kahirupan.
  • Nalika lesion ningkat, hyperpigmentation pos-radang bisa muncul.
  • Ieu bisa disababkeun ku tatu dina lontar.
  • Kasus biasa
  • Lamun patch erythematous lembut nyebar gancang, Selulitis (Cellulitis) kudu disangka.
  • Salaku Selulitis (Cellulitis) ningkat, sél kulit paéh bisa mesek, sarta bisa jadi itchy.
  • Kalolobaan Selulitis (Cellulitis) dipirig ku bareuh jeung erythema di wewengkon sabudeureun. Nanging, dina kasus anu luar biasa ieu dimana henteu aya erythema di sakurilingna, karsinoma sél skuamosa ogé kedah disangka.
  • Kasus has
  • Fase penyembuhan.
References Cellulitis 31747177 
NIH
Cellulitis mangrupakeun inféksi kulit baktéri umum. Éta mangaruhan langkung ti 14 juta jalma unggal taun di Amérika Serikat. Éta nyababkeun sakitar $ 3. 7 milyar dina biaya perawatan ambulatory sareng 650,000 rawat inap unggal taun. Ilaharna, cellulitis muncul salaku wewengkon beureum haneut dina kulit jeung bareuh jeung tenderness. Éta disababkeun ku inféksi baktéri ngadadak anu memicu peradangan dina lapisan kulit jero sareng jaringan caket dieu. Henteu aya bisul atanapi nanah sareng inféksi ieu. Streptococci béta-hemolytic, utamana grup A streptococcus (Streptococcus pyogenes) , mangrupakeun culprits biasa, dituturkeun ku methicillin-sensitive Staphylococcus aureus.
Cellulitis is a common bacterial skin infection, with over 14 million cases occurring in the United States annually. It accounts for approximately 3.7 billion dollars in ambulatory care costs and 650000 hospitalizations annually. Cellulitis typically presents as a poorly demarcated, warm, erythematous area with associated edema and tenderness to palpation. It is an acute bacterial infection causing inflammation of the deep dermis and surrounding subcutaneous tissue. The infection is without an abscess or purulent discharge. Beta-hemolytic streptococci typically cause cellulitis, generally group A streptococcus (i.e., Streptococcus pyogenes), followed by methicillin-sensitive Staphylococcus aureus. Patients who are immunocompromised, colonized with methicillin-resistant Staphylococcus aureus, bitten by animals, or have comorbidities such as diabetes mellitus may become infected with other bacteria.
 Cellulitis: current insights into pathophysiology and clinical management 29219814
Cellulitis mangrupikeun inféksi baktéri dina kulit sareng jaringan lemes. Éta kajadian nalika aya masalah sareng halangan pelindung kulit, sistem imun, atanapi sirkulasi getih. Diabetes, obesitas, sareng umur sepuh ningkatkeun kamungkinan cellulitis ku mangaruhan daérah ieu. Urang ogé nempo papanggihan panganyarna dina diagnosing cellulitis , panyorot pentingna diagnosis akurat saprak kaayaan kawas insufficiency venous, éksim, deep vein thrombosis, sarta asam urat mindeng bingung jeung cellulitis. Antibiotik anu dianggo pikeun ngubaran cellulitis dipilih sacara saksama pikeun nargétkeun baktéri umum tanpa ngadorong résistansi antibiotik. Urang ogé ngobrol ngeunaan antibiotik anyar disatujuan pikeun cellulitis. Cellulitis sering datang deui kusabab faktor résiko sareng karusakan sistem limfatik.
Cellulitis is a bacterial infection of the skin and soft tissues. It happens when there are issues with the skin's protective barrier, the immune system, or blood circulation. Diabetes, obesity, and old age increase the chances of cellulitis by affecting these areas. We also look at recent findings on diagnosing cellulitis, highlighting the importance of accurate diagnosis since conditions like venous insufficiency, eczema, deep vein thrombosis, and gout are often confused with cellulitis. Antibiotics used to treat cellulitis are chosen carefully to target common bacteria without encouraging antibiotic resistance. We also talk about new antibiotics approved for cellulitis. Cellulitis often comes back because of ongoing risk factors and damage to the lymphatic system..
 Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Seueur jalma angkat ka rumah sakit atanapi kamar darurat pikeun inféksi kulit baktéri anu ngadadak. Staphylococcus aureus mangrupikeun kuman utama anu nyababkeun inféksi ieu, sareng janten langkung hese diubaran kusabab sababaraha galur tahan ka antibiotik umum.
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus bisa dibagi jadi dua jenis dumasar kana respon maranéhanana ka antibiotik: methicillin-sensitive Staphylococcus aureus (MSSA) , methicillin-resistant Staphylococcus aureus (MRSA) . Dina sababaraha dasawarsa katukang, kusabab évolusi baktéri sareng kaleuleuwihan antibiotik, résistansi S. Aureus ka ubar parantos ningkat, nyababkeun paningkatan global dina tingkat inféksi MRSA.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.